Join Us at the 2022 National Alzheimer's Summit

Throughout two half-days, October 12-13, sessions will cover the latest scientific developments in prevention, early detection, and treatment—with a focus on ensuring more equitable access to innovations for everyone.

Say Hello to BrainGuide

Our platform BrainGuide™ empowers people of all ages and communities to understand and take action on brain health and Alzheimer's disease.

The Brain Health Academy

Free, evidence-based courses to equip healthcare and wellness providers with the knowledge and resources to help people reduce the risk of dementia and Alzheimer’s. Next Session: Social Isolation, Loneliness and Dementia September 14

Major Win for Alzheimer’s Patients as U.S. House Committee Announces Significant Investments in Fighting Alzheimer’s

The fight to end Alzheimer’s got a major boost today as the U.S. House Appropriations Committee passed significant funding increases for Alzheimer’s research, prevention, and treatment.

UsAgainstAlzheimer’s Urges CMS to Reconsider Rule Limiting Access to PET Scans

UsAgainstAlzheimer’s Urges CMS to Reconsider Rule Limiting Access to PET Scans

UsAgainstAlzheimer’s chair and co-founder George Vradenburg submitted public comment to Centers for Medicare and Medicare Services (CMS) urging the agency to reconsider their National Coverage Determination (NCD) and provide coverage without CED for the FDA-approved use of amyloid-beta PET scan.

New Survey: Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments

A new A-LIST® survey of people with Alzheimer’s and Alzheimer’s caregivers shows that 75 percent want Medicare to cover new therapies—even after they are told that the drugs have a risk of side effects and still require confirmatory trials.

You don't want to miss this!

Say Hello to BrainGuide

The Brain Health Academy

Major Win for Alzheimer’s Patients as U.S. House Committee Announces Significant Investments in Fighting Alzheimer’s

UsAgainstAlzheimer’s Urges CMS to Reconsider Rule Limiting Access to PET Scans

Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments

UsAgainstAlzheimer's: Working to End Alzheimer's Disease  

The Alzheimer’s pandemic is one of the most significant health and social economic crises of this generation. It is a national and global emergency that has a devastating health, social and economic toll on millions of people living with this disease, their families and caregivers.

UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. Since our founding in 2010, we have taken on the toughest problems in the fight to end Alzheimer’s. Our work is driven by the urgency to find effective treatments and the prevention steps needed to reach the time where no one is lost to Alzheimer’s.

We bring all of “Us” together to:

In the past decade, progress has been made, with more hope on the horizon now than ever before.

But every day of delay is another day lost to the millions of people affected by this devastating disease. If nothing changes, by 2050, 14 million Americans will be living with Alzheimer’s at an annual cost of more than $1 trillion. The time to act is now.

Recent News and Blog Posts

  • Letter from Leading Alz Researchers: Journal “overstates and distorts” influence of flawed 2016 study

    In a letter to the editor published in Science responding to the...

    Read more
  • August 08, 2022

    FDA Deals Major Blow to Patients with Alzheimer’s-Related Psychosis

    Yesterday, Acadia Pharmaceuticals announced that it has been told by the FDA...

    Read more
  • A-LIST Pulse of the Community Vol 12, August 2022

    The mission of the A-LIST is to leverage data to make life...

    Read more
  • July 18, 2022

    UsAgainstAlzheimer’s Urges CMS to Reconsider Rule Limiting Access to PET Scans

    Washington, D.C. (July 15, 2022) – UsAgainstAlzheimer’s chair and co-founder George Vradenburg ...

    Read more
  • June 30, 2022

    Major Win for Alzheimer’s Patients as U.S. House Committee Announces Significant Investments in Fighting Alzheimer’s

    Washington, D.C. – The fight to end Alzheimer’s got a major boost...

    Read more
  • June 28, 2022

    New Data Shows Hope for Reducing Agitation in Alzheimer’s Patients

    Washington, D.C. – Today, UsAgainstAlzheimer’s hailed the release of a new data...

    Read more

Reports

  • Resources
    Us Against Alzheimer's 2021 Annual Report

    2021 Annual Report

    With breakthroughs in treatment, a remarkable step forward in prevention, and a new initiative to raise public awareness of the importance of brain health, many efforts were led by UsAgainstAlzheimer’s...

  • Resources
    A-List 2017-2022 surveys

    A-List What Matters Most Surveys

    A-List 2017-2022 surveys, updated July 2022

  • Resources

    A-LIST Pulse of the Community - December 2021